Piper Sandler reiterates USD 370 target for Cigna Group stock

Published on 10/27/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna set adjusted EPS guidance at least USD 30.45 on September 30, 2026. Cigna Group stock costs EUR 274.95, 0.57 percent above Xetra's close.

Target and earnings calendar

Piper Sandler reiterated a USD 370.00 target for Cigna Group on October 23, 2026.
The Cigna Group set adjusted earnings per share guidance of at least USD 30.45 on September 30, 2026.
Cigna Group stock trades at EUR 274.95 at 10:34 a.m. CEST at Lang & Schwarz on October 27, 2026, 0.57 percent above the Xetra close of October 26, 2026.
Third-quarter results are scheduled for November 5, 2026.

Cigna Group, US1255231003, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) was trading at EUR 274.95 at Lang & Schwarz on October 27, 2026 at 10:34 a.m. CEST. Investing.com reported on October 23, 2026 that Piper Sandler reiterated an Overweight rating and a USD 370.00 price target for the stock.

Analyst target meets a strategy reset

The analyst view followed Cigna's September strategy update rather than a new quarterly report. At its Investor Day, PR Newswire carried the company's September 30, 2026 guidance for adjusted earnings per share of at least USD 30.45 and a medical care ratio of 83.7 percent to 84.7 percent. The same release described a USD 3.00 billion modernization and productivity initiative.

The latest reported quarter gives the target a measurable operating backdrop. For the second quarter of 2026, Cigna posted revenue of USD 71.56 billion, up 6.7 percent from the prior-year quarter, and adjusted earnings per share of USD 7.78 versus a USD 7.60 consensus estimate, according to MarketBeat. Revenue therefore exceeded the cited consensus by USD 1.42 billion.

What does the target imply?

Piper Sandler linked its view to pharmacy benefit economics and Cigna's transition toward a rebate-free model. Its October 23 analysis said the company would need an administrative fee of USD 13.09 per member per month to maintain Pharmacy Benefit Services profitability at 2026 levels if the business fully moved to its Signature model, as reported by Investing.com.

Three dates frame the next move

On July 30, 2026, Cigna reported second-quarter revenue of USD 71.56 billion and adjusted earnings per share of USD 7.78, according to MarketBeat. On September 30, 2026, the company announced its USD 3.00 billion modernization program and reaffirmed adjusted earnings per share guidance of at least USD 30.45 through PR Newswire. On October 23, 2026, Piper Sandler reiterated its USD 370.00 target through Investing.com.

Next report arrives November 5

PR Newswire said on October 9, 2026 that Cigna will release third-quarter 2026 results on November 5, 2026, no later than 6:30 a.m. ET, followed by a conference call at 8:30 a.m. ET.

Stock holds above the Xetra close

Cigna Group stock was trading at EUR 274.95 at Lang & Schwarz on October 27, 2026 at 10:34 a.m. CEST, up EUR 1.55 or 0.57 percent versus the Xetra close of October 26, 2026 at EUR 273.40. The finance snapshot shows a 52-week range of EUR 208.40 to EUR 282.00 and a market capitalization of USD 81.1 billion as of October 26, 2026. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.